DTP Branches and Offices
Last Updated: 11/07/22
Funding Opportunities
Funding Opportunity Announcements
| Title | Announcement Number | Opening Date | Expiration Date | Activity Code |
|---|---|---|---|---|
| Assay development and screening for discovery of chemical probes, drugs or immunomodulators | PAR-20-271 | Sep 5, 2020 | Jan 08, 2023 | R01 |
| Advancing the development of tumor site-activated small molecules | NOT-CA-21-101 | Jan 26, 2022 | Jan 08, 2024 | R01, R21 |
| NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) | PAR-22-216 | Sep 10, 2022 | July 2, 2025 | R21 |
DCTD Funding Opportunity in Translational Research
| Title | Announcement Number | Opening Date | Expiration Date | Activity Code |
|---|---|---|---|---|
| NCI Clinical and Translational Exploratory/Developmental Studies | PAR-22-216 | Sep 10, 2022 | July 2, 2025 | R21 |
NIH Parent Announcements
About the Branch Chief
Dr. Sundar Venkatachalam serves as the chief of PTGB. Sundar earned his Ph.D. in Biochemistry from the Ohio State University, where he studied the molecular mechanisms of DNA damage and repair responses induced by polycyclic aromatic hydrocarbons. As a postdoctoral fellow at the Baylor College of Medicine, he analyzed the role of the p53 haploinsufficiency in tumor susceptibility and aging using genetically engineered mouse models. More…